Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €127.75 | €137.63 | 7.737% |
| Tenet Healthcare | 23 | 0 | 3 | 0 | €91.00 | €95.79 | 5.269% |
| Icon plc | 18 | 0 | 6 | 0 | €280.00 | €318.99 | 13.927% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | €10.61 | €22.78 | 114.760% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.94 | €26.01 | 18.534% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €41.60 | €82.93 | 99.354% |
| United Therapeutics | 15 | 0 | 0 | 0 | €220.00 | €289.92 | 31.782% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €153.05 | €215.54 | 40.828% |
| Amedisys Inc. | 13 | 0 | 1 | 0 | €83.50 | €92.26 | 10.491% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €68.50 | €86.72 | 26.594% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €154.50 | €182.96 | 18.421% |
| Halozyme Therapeutics Inc. | 12 | 0 | 1 | 0 | €36.53 | €54.21 | 48.398% |
| Alkermes plc | 12 | 2 | 2 | 0 | €22.40 | €34.08 | 52.146% |
| Molina Healthcare | 11 | 1 | 1 | 1 | €323.40 | €359.93 | 11.297% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.30 | €421.61 | 16.049% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €212.30 | €247.61 | 16.631% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.30 | €31.74 | 73.437% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €58.50 | €75.80 | 29.573% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.70 | €65.00 | -3.988% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €80.50 | €97.90 | 21.617% |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €100.60 | €110.00 | 9.344% |
| LivaNova plc | 7 | 0 | 2 | 0 | €51.00 | €64.66 | 26.782% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |